Wagner, P. M., Monjes, N. M., & Guido, M. E. (2019). Chemotherapeutic effect of SR9009, a REV-ERB agonist, on the human glioblastoma T98G cells. Web
Citación estilo ChicagoWagner, Paula Micaela, Natalia Maribel Monjes, and Mario Eduardo Guido. Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, On the Human Glioblastoma T98G Cells. 2019.
Cita MLAWagner, Paula Micaela, Natalia Maribel Monjes, and Mario Eduardo Guido. Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, On the Human Glioblastoma T98G Cells. 2019.
Precaución: Estas citas no son 100% exactas.